Abstract
Epigenetic modifications, such as DNA methylation and histone acetylation, are well established as important players in tumourigenesis and thereby sought after targets in therapeutic intervention. Recent years have seen an increase in the research and clinical development of histone deacetylase (HDAC) inhibitors as anti-cancer agents, but emerging evidence now suggests that the class of enzymes performing the reciprocal function of histone acetylation, histone acetyltransferases (HATs), may also have pivotal roles in cancer progression. Here we discuss the role of HAT complexes in tumourigenesis and their potential as bona fide druggable cancer targets, focusing in particular on the evolutionary conserved TIP60 complex.
Keywords: Acetylation, cancer, epigenetics, HAT inhibitors, histone acetyltransferases, MRGBP, TIP60, tumour therapy.
Drug Delivery Letters
Title:Tipping the Balance Between Life and Death: Targeting Histone Acetylation for Cancer Therapy
Volume: 3 Issue: 2
Author(s): Stephen A. Watt and Andrew P. South
Affiliation:
Keywords: Acetylation, cancer, epigenetics, HAT inhibitors, histone acetyltransferases, MRGBP, TIP60, tumour therapy.
Abstract: Epigenetic modifications, such as DNA methylation and histone acetylation, are well established as important players in tumourigenesis and thereby sought after targets in therapeutic intervention. Recent years have seen an increase in the research and clinical development of histone deacetylase (HDAC) inhibitors as anti-cancer agents, but emerging evidence now suggests that the class of enzymes performing the reciprocal function of histone acetylation, histone acetyltransferases (HATs), may also have pivotal roles in cancer progression. Here we discuss the role of HAT complexes in tumourigenesis and their potential as bona fide druggable cancer targets, focusing in particular on the evolutionary conserved TIP60 complex.
Export Options
About this article
Cite this article as:
Watt A. Stephen and South P. Andrew, Tipping the Balance Between Life and Death: Targeting Histone Acetylation for Cancer Therapy, Drug Delivery Letters 2013; 3 (2) . https://dx.doi.org/10.2174/2210303111303020007
DOI https://dx.doi.org/10.2174/2210303111303020007 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot topic: Breast Cancer: Novel Therapeutic Targets (Guest Editor: George W. Yip)]
Recent Patents on Anti-Cancer Drug Discovery Antineoplastic and Antimicrobial Potential of Novel Phytofabricated Silver Nanoparticles from <i>Pterospermum acerifolium</i> Leaf Extract
Nanoscience & Nanotechnology-Asia Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway
Current Cancer Therapy Reviews Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets
Current Pharmaceutical Design Long-Term Immunovirogical Effect and Tolerability of a Maraviroc- Containing Regimen in Routine Clinical Practice
Current HIV Research Tamoxifen Citrate Loaded Ethosomes for Transdermal Drug Delivery System: Preparation and Characterization
Current Drug Delivery The Intestinal Environment in Health and Disease – Recent Insights on the Potential of Intestinal Bacteria to Influence Human Health
Current Pharmaceutical Design L-Thyroxine Acts as a Hormone as well as a Prohormone at the Cell Membrane
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Molecular Basis of Therapeutic Strategies for Breast Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Antiandrogens in Prostate Cancer Endocrine Therapy
Current Cancer Drug Targets The Progress of the Anticancer Agents Related to the Microtubules Target
Mini-Reviews in Medicinal Chemistry Insights on Melatonin as an Active Pharmacological Molecule in Cancer Prevention: What’s New?
Current Medicinal Chemistry Targeted Therapy in Advanced Gastric Carcinoma: The Future is Beginning
Current Medicinal Chemistry Therapeutic Antibodies and Other Proteins Obtained by Molecular Display Technologies
Recent Patents on Biotechnology The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry RNA Interference: New Therapeutics in Allergic Diseases
Current Gene Therapy High-Risk HPV/ErbB-2 Interaction on E-Cadherin/Catenin Regulation in Human Carcinogenesis
Current Pharmaceutical Design Chronopharmaceutics: A Promising Drug Delivery Finding of the Last Two Decades
Recent Patents on Drug Delivery & Formulation Editorial: Neuronanomedicine - (Part II)
Current Medicinal Chemistry Mitochondria as Possible Pharmaceutical Targets for the Effects of Vitamin E and its Homologues in Oxidative Stress-Related Diseases
Current Pharmaceutical Design